Exact Mass: 362.06935480000004
Exact Mass Matches: 362.06935480000004
Found 72 metabolites which its exact mass value is equals to given mass value 362.06935480000004,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Fosphenytoin
Fosphenytoin is a water-soluble phenytoin prodrug used only in hospitals for the treatment of epileptic seizures. It works by slowing down impulses in the brain that cause seizures. Its main mechanism is to block frequency-dependent, use-dependent and voltage-dependent neuronal sodium channels, and therefore limit repetitive firing of action potentials. N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AB - Hydantoin derivatives C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators
Polyribophosphate
C10H19O12P (362.06141040000006)
5,8,3,4,5-Pentahydroxy-3,7-dimethoxyflavone
3a,4-dihydroxy-3-(4-hydroxy-5-oxo-2,5-dihydro-furan-2-yloxymethylene)-5-methoxy-3,3a,8,8a-tetrahydro-1-oxa-cyclopenta[a]inden-2-one|peagol
3,4,7-Tri-Me ether-3,3,4,5,5,7,8-Heptahydroxyflavone
1-bromo-4-(2-chloro-1-ethyl-2-methyl-pentyloxy)-3-epi-methoxy-4,6,6-trimethyl-cyclohexene|cycloelatanene B
3,4,8-Tri-Me ether-3,3,4,5,5,7,8-Heptahydroxyflavone
5,5-Bis(3,3-Dimethoxy-1-propinyl)-2,2-bithienyl|5,5-bis-(3,3-dimethoxy-prop-1-ynyl)-[2,2]bithiophenyl
3,5,8-Tri-Me ether-2,3,4,5,5,7,8-Heptahydroxyflavone
5-(4,4,6-trimethyl-2-thioxo-3,4-dihydropyrimidin-1(2H)-yl)naphthalene-2-sulfonic acid
ethyl 3-(N-(5-chloro-2-nitrophenyl)anilino)-3-oxopropanoate
C17H15ClN2O5 (362.06694500000003)
n-(2-hydroxyethyl)ethylenediaminetriacetic acid, trisodium salt hydrate, 85
C10H17N2Na3O8 (362.06779620000003)
9-FLUORENYLMETHYL N-(2-AMINOETHYL)CARBAMATE HYDROBROMIDE
C17H19BrN2O2 (362.06298139999996)
sodium,3,7-dimethylpurine-2,6-dione,2-hydroxybenzoate
4-BENZYLOXY-5-BROMO-2-(4-METHYLPIPERAZIN-1-YL)-PYRIMIDINE
C16H19BrN4O (362.07421439999996)
N-(5-AMINOPENTYL)-5-CHLORO-1-NAPHTHALENE-SULFONAMIDE HYDROCHLORIDE
4-(dimethylsulfamoyl)-N-[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]benzamide
C15H14N4O5S (362.06848740000004)
1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone
3-(2-chloro-6-fluorophenyl)-N-(3-fluoro-4-methylphenyl)-5-methyl-4-isoxazolecarboxamide
3-[(1,3-benzothiazol-2-ylthio)methyl]-4-cyclohexyl-1H-1,2,4-triazole-5-thione
C16H18N4S3 (362.06935480000004)
5-[(2-Chlorophenyl)methylsulfonyl]-1-(2,6-dimethylphenyl)tetrazole
8-Chloro-7-[2-(4-methoxyphenyl)-2-oxoethyl]-1,3-dimethylpurine-2,6-dione
C16H15ClN4O4 (362.07817800000004)
3-(2-chlorophenyl)-5-methyl-N-(5-propan-2-yl-1,3,4-thiadiazol-2-yl)-4-isoxazolecarboxamide
N-[5-(2-methoxyphenyl)-1,3,4-thiadiazol-2-yl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide
C14H14N6O2S2 (362.06196239999997)
2-[4,6-dihydroxy-2-methoxy-3-[(E)-3-methyl-4-sulfooxybut-2-enyl]phenyl]acetic acid
C14H18O9S (362.06714980000004)
2-[4,6-Dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-2-sulooxyacetic acid
C14H18O9S (362.06714980000004)
Fosphenytoin
N - Nervous system > N03 - Antiepileptics > N03A - Antiepileptics > N03AB - Hydantoin derivatives C78272 - Agent Affecting Nervous System > C264 - Anticonvulsant Agent D002491 - Central Nervous System Agents > D000927 - Anticonvulsants D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers D049990 - Membrane Transport Modulators
ZINC00784494
C20H14N2O3S (362.07250940000006)
ZINC00784494 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00784494 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00784494 has good potential for research in inflammatory breast cancer (IBC)[1].
5,14,15-trihydroxy-4-(hydroxymethyl)-7,12-dimethyl-10-oxo-2,9-dioxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3,5,7,12,14-hexaene-6-carboxylic acid
methyl 2-(1,2,3,6,7,8-hexahydroxy-10-oxo-9h-anthracen-9-yl)acetate
(6r)-6,9,10-trihydroxy-8-methoxy-1-oxo-3-[(1e)-prop-1-en-1-yl]-6h-pyrano[4,3-c]isochromene-7-carboxylic acid
4-(4-carboxy-2-methoxyphenoxy)-5-methoxybenzene-1,2-dicarboxylic acid
4-(5-carboxy-2,3-dimethoxyphenoxy)benzene-1,3-dicarboxylic acid
5,8-dihydroxy-3,7-dimethoxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
6,6-dimethyl-5,12,18,20,24-pentaoxahexacyclo[12.10.0.0²,¹¹.0⁴,⁹.0¹⁵,²³.0¹⁷,²¹]tetracosa-1(14),2(11),3,7,9,15(23),16,21-octaen-13-one
6,9,10-trihydroxy-8-methoxy-1-oxo-3-[(1e)-prop-1-en-1-yl]-6h-pyrano[4,3-c]isochromene-7-carboxylic acid
5-hydroxy-3-(4-hydroxy-5-methyl-2-oxochromen-3-yl)-2-methylnaphthalene-1,4-dione
(1r,1'r,10'r,12'r)-7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione
5,7-dihydroxy-3,6-dimethoxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
6,9,10-trihydroxy-8-methoxy-1-oxo-3-(prop-1-en-1-yl)-6h-pyrano[4,3-c]isochromene-7-carboxylic acid
7'-hydroxy-5-methoxy-2',11'-dioxaspiro[naphthalene-1,3'-tetracyclo[6.4.1.0⁴,¹³.0¹⁰,¹²]tridecane]-4'(13'),5',7'-triene-4,9'-dione
(1s)-7-methoxy-1-methyl-14-oxapentacyclo[11.6.1.0²,¹¹.0⁴,⁹.0¹⁶,²⁰]icosa-2(11),3,6,9,13(20),15-hexaene-5,8,12,17-tetrone
(6s)-6-(prop-1-en-2-yl)-7,11,17,19,23-pentaoxahexacyclo[11.10.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tricosa-1(13),2(10),3,8,14(22),15,20-heptaen-12-one
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6,8-dimethoxychromen-4-one
3-(4-hydroxyphenyl)-7-[(4-hydroxyphenyl)sulfanyl]cyclohepta[b]furan-2-one
C21H14O4S (362.06127640000005)